These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2. Gamonal SBL; Marques NCV; Pereira HMB; Gamonal ACC Dermatol Ther; 2022 Sep; 35(9):e15677. PubMed ID: 35770484 [No Abstract] [Full Text] [Related]
4. Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford-AstraZeneca) Vaccination. Ali A; Rabouhans J; Salar T; Moghul S; Makkuni S; Browne T; Ahmed R; Syed I; Zaman A Cardiovasc Intervent Radiol; 2022 Mar; 45(3):398-401. PubMed ID: 35043242 [No Abstract] [Full Text] [Related]
5. Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients. David R; Hanna P; Lee K; Ritchie A Nephrology (Carlton); 2022 Jan; 27(1):109-110. PubMed ID: 34755433 [No Abstract] [Full Text] [Related]
6. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217 [TBL] [Abstract][Full Text] [Related]
7. Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature. Singh A; Bharadwaj SJ; Chirayath AG; Ganguly S J Cosmet Dermatol; 2022 Jun; 21(6):2311-2314. PubMed ID: 35348281 [TBL] [Abstract][Full Text] [Related]
8. A case of interstitial lung disease following Oxford-AstraZeneca COVID-19 vaccination. Taverner JVB; Robertson JG Intern Med J; 2022 Jul; 52(7):1276-1277. PubMed ID: 35879232 [No Abstract] [Full Text] [Related]
9. Disseminated and localised herpes zoster following Oxford-AstraZeneca COVID-19 vaccination. Jiang ZH; Wong LS; Lee CH; Hsu TJ; Yu YH Indian J Dermatol Venereol Leprol; 2022; 88(3):445. PubMed ID: 35389012 [No Abstract] [Full Text] [Related]
10. A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination. Kim SH; Lee SY; Kim GY; Oh JS; Kim J; Chun KJ; Ju MH; Lee CH; Song YJ; Na JY J Korean Med Sci; 2022 Apr; 37(13):e104. PubMed ID: 35380028 [TBL] [Abstract][Full Text] [Related]
11. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426 [TBL] [Abstract][Full Text] [Related]
12. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. Jarius S; Bieber N; Haas J; Wildemann B J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110 [TBL] [Abstract][Full Text] [Related]
13. Central nervous system adverse events after ChAdOx1 vaccination. Maramattom BV; Lotlikar RS; Sukumaran S Neurol Sci; 2022 Jun; 43(6):3503-3507. PubMed ID: 35275317 [TBL] [Abstract][Full Text] [Related]
14. Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases. Nagrani P; Jindal R; Goyal D Dermatol Ther; 2021 Sep; 34(5):e15085. PubMed ID: 34350668 [No Abstract] [Full Text] [Related]
15. Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Varona JF; García-Isidro M; Moeinvaziri M; Ramos-López M; Fernández-Domínguez M Eur J Intern Med; 2021 Sep; 91():90-92. PubMed ID: 34256983 [No Abstract] [Full Text] [Related]
17. Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis. Yang IN; Lu CL; Tang HJ; Kuo YC; Tsai LH; Tu KC; Wang JJ; Chien CC PLoS One; 2022; 17(9):e0273676. PubMed ID: 36084024 [TBL] [Abstract][Full Text] [Related]